https://finance.yahoo.com/news/pfizer-says-early-studies-potential-105622647.html"It also said it plans to support studies to determine whether existing Pfizer medicines, including its rheumatoid arthritis drug Xeljanz, may provide benefits for those struggling with the COVID-19 respiratory illness caused by the coronavirus."